Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells

[1]  Yu Tian Wang,et al.  MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models. , 2019, Signal Transduction and Targeted Therapy.

[2]  P. Vangheluwe,et al.  Dimethyl fumarate alters intracellular Ca2+ handling in immune cells by redox-mediated pleiotropic effects. , 2019, Free radical biology & medicine.

[3]  Hassan K. Obied,et al.  Olive Biophenols Reduces Alzheimer’s Pathology in SH-SY5Y Cells and APPswe Mice , 2018, International journal of molecular sciences.

[4]  Karolina Pierzynowska,et al.  Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer’s disease , 2018, Brain Research.

[5]  S. Kügler,et al.  Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy , 2017, Redox biology.

[6]  P. Palumaa,et al.  In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells , 2017, PloS one.

[7]  S. Cuzzocrea,et al.  Multiple mechanisms of dimethyl fumarate in amyloid β‐induced neurotoxicity in human neuronal cells , 2017, Journal of cellular and molecular medicine.

[8]  Pedro Rosa-Neto,et al.  Synergistic interaction between amyloid and tau predicts the progression to dementia , 2017, Alzheimer's & Dementia.

[9]  A. Oliveira‐Brett,et al.  Alzheimer's disease amyloid beta peptides in vitro electrochemical oxidation. , 2017, Bioelectrochemistry.

[10]  T. Wisniewski,et al.  Alzheimer’s disease: experimental models and reality , 2017, Acta Neuropathologica.

[11]  H. Hayashi,et al.  Involvement of GSK-3β Phosphorylation Through PI3-K/Akt in Cerebral Ischemia-Induced Neurogenesis in Rats , 2016, Molecular Neurobiology.

[12]  N. Inestrosa,et al.  How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario , 2015, Front. Cell. Neurosci..

[13]  L. Shriver,et al.  Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes , 2015, Redox biology.

[14]  A. Hake,et al.  Alzheimer's disease clinical trials: past failures and future opportunities , 2015 .

[15]  D. Arnold,et al.  Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis , 2015, European journal of neurology.

[16]  G. Bloom.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. , 2014, JAMA neurology.

[17]  A. Mietelska-Porowska,et al.  Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction , 2014, International journal of molecular sciences.

[18]  L. Serpell,et al.  The relationship between amyloid structure and cytotoxicity , 2014, Prion.

[19]  F. Kees.  Dimethyl fumarate: a Janus-faced substance? , 2013, Expert opinion on pharmacotherapy.

[20]  N. Inestrosa,et al.  Canonical Wnt signaling protects hippocampal neurons from Aβ oligomers: role of non-canonical Wnt-5a/Ca2+ in mitochondrial dynamics , 2013, Front. Cell. Neurosci..

[21]  I. Parker,et al.  Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate , 2013, The Journal of Neuroscience.

[22]  Qiang Wu,et al.  Effect of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced tau protein hyperphosphorylation , 2013, Behavioural Brain Research.

[23]  C. Oliveira,et al.  Amyloid-beta peptide 1-42 causes microtubule deregulation through N-methyl-D-aspartate receptors in mature hippocampal cultures. , 2012, Current Alzheimer research.

[24]  Yuhong Yang,et al.  Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling* , 2012, The Journal of Biological Chemistry.

[25]  J. Garrido,et al.  Molecular Neuroscience Review Article Modulation of Gsk-3 as a Therapeutic Strategy on Tau Pathologies Role and Regulation of Gsk-3 Activity , 2022 .

[26]  Shaomin Li,et al.  Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.

[27]  A. Miranker,et al.  Protein-induced photophysical changes to the amyloid indicator dye thioflavin T , 2010, Proceedings of the National Academy of Sciences.

[28]  E. F. da Cruz e Silva,et al.  Aβ promotes Alzheimer’s disease‐like cytoskeleton abnormalities with consequences to APP processing in neurons , 2010, Journal of neurochemistry.

[29]  R. Youle,et al.  The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.

[30]  Jianqing Ding,et al.  Protective effects of erythropoietin on tau phosphorylation induced by β‐amyloid , 2008, Journal of neuroscience research.

[31]  L. Serpell,et al.  Amyloid fibrils , 2008, Prion.

[32]  Ying Jin,et al.  Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus , 2006, Acta Pharmacologica Sinica.

[33]  J. Lucas,et al.  Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3 , 2006, The Journal of Neuroscience.

[34]  Thuy-vi Nguyen,et al.  β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w , 2005, The Journal of Neuroscience.

[35]  Y. Surh,et al.  Bcl-2 protects against Abeta(25-35)-induced oxidative PC12 cell death by potentiation of antioxidant capacity. , 2004, Biochemical and biophysical research communications.

[36]  L. K. Baker,et al.  Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.

[37]  H. Joshi,et al.  Differential utilization of beta-tubulin isotypes in differentiating neurites , 1989, The Journal of cell biology.

[38]  R. Cole,et al.  Effect of ATP on the kinetics of microtubule assembly. , 1982, The Journal of biological chemistry.

[39]  Brendon M. Baker,et al.  Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. , 2018, The Journal of investigative dermatology.

[40]  Fei Liu,et al.  Tau and neurodegenerative disease: the story so far , 2016, Nature Reviews Neurology.

[41]  Justin C. Y. Wu,et al.  Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. , 2014, Journal of Alzheimer's disease : JAD.

[42]  Qiang Du,et al.  Cross-Regulation Between Wnt and NF-κB Signaling Pathways. , 2010, Forum on immunopathological diseases and therapeutics.

[43]  Gregory J Brewer,et al.  Amyloid-β as a modulator of synaptic plasticity. , 2010, Journal of Alzheimer's disease : JAD.

[44]  John M. Walker,et al.  The Protein Protocols Handbook , 1996, Humana Press.

[45]  J M Walker,et al.  The bicinchoninic acid (BCA) assay for protein quantitation. , 1994, Methods in molecular biology.